Patient refusal of thrombolytic therapy for suspected acute ischemic stroke

International Journal of Stroke

Volumn 10, Issue 6, 2015, Pages 882-886

  Vahidy, F S ^a   Rahbar, M H ^b,c   Lal, A P ^a   Grotta, J C ^a   Savitz, S I ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute stroke therapy; Ischemic stroke; Refusal; rtPA; Stroke; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG UTILIZATION; EMERGENCY WARD; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TREATMENT REFUSAL; MIDDLE AGED; PROBABILITY; PSYCHOLOGY; REGISTER; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROBABILITY; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 84938066818     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00945.x     Document Type: Article

References (16)

1. Lloyd-Jones D, Adams R, Carnethon M etal. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:e21-181.
2. George MG, Tong X, McGruder H etal. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007. MMWR Surveill Summ 2009; 58:1-23.
3. Bambauer KZ, Johnston SC, Bambauer DE, Zivin JA. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 2006; 63:661-664.
4. Barber PA, Zhang J, Demchuk AM etal. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56:1015-1020.
5. Smith EE, Abdullah AR, Petkovska I etal. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 2005; 36:2497-2499.
6. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
7. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40:2945-2948.
8. Reeves MJ, Arora S, Broderick JP etal. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005; 36:1232-1240.
9. Rymer MM, Thrutchley DE. Organizing regional networks to increase acute stroke intervention. Neurol Res 2005; 27(Suppl. 1):S9-16.
10. StataCorp. Stata Statistical Software. Release 11. College Station, TX, StataCorp LP, 2009.
11. Kleindorfer D, Khoury J, Broderick JP etal. Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment. Stroke 2009; 40:2502-2506.
12. Chernyshev OY, Martin-Schild S, Albright KC etal. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 2010; 74:1340-1345.
13. Hassan AE, Hassanzadeh B, Tohidi V etal. Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage. South Med J 2010; 103:398-402.
14. Hassan AE, Zacharatos H, Hassanzadeh B etal. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator? J Stroke Cerebrovasc Dis 2010; 19:116-120.
15. Faden R, Faden A. False belief and the refusal of medical treatment. J Med Ethics 1977; 3:133-136.
16. Sharp HM, Bryant KN. Ethical issues in dysphagia: when patients refuse assessment or treatment. Semin Speech Lang 2003; 24:285-299.